Gliptin
Pricing regulator closely watching prices of diabetes drug going off patent
Regulator looking to cap prices of Sitagliptin, Linagliptin and combinations
 "Pricing regulator closely watching prices of diabetes drug going off patent")
Updated On : 28 Aug 2022 | 11:59 PM IST
Generic gliptin's market grows at the expense of patented medicines
Once the generic version has more trial data, it's most likely to obliterate its patented counterparts in the future
 "Generic gliptin's market grows at the expense of patented medicines")
Updated On : 08 Mar 2016 | 2:49 PM IST
